173 related articles for article (PubMed ID: 9205223)
1. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.
Kinkel K; Ariche M; Tardivon AA; Spatz A; Castaigne D; Lhomme C; Vanel D
Radiology; 1997 Jul; 204(1):55-63. PubMed ID: 9205223
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients.
Kinkel K; Tardivon AA; Soyer P; Spatz A; Lasser P; Rougier P; Vanel D
Radiology; 1996 Aug; 200(2):453-8. PubMed ID: 8685341
[TBL] [Abstract][Full Text] [Related]
3. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
4. MR imaging of pelvic masses in women: contrast-enhanced vs unenhanced images.
Thurnher SA
AJR Am J Roentgenol; 1992 Dec; 159(6):1243-50. PubMed ID: 1442393
[TBL] [Abstract][Full Text] [Related]
5. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of locally recurrent pelvic malignancy: performance of T2- and diffusion-weighted MRI with image fusion.
Nishie A; Stolpen AH; Obuchi M; Kuehn DM; Dagit A; Andresen K
J Magn Reson Imaging; 2008 Sep; 28(3):705-13. PubMed ID: 18777555
[TBL] [Abstract][Full Text] [Related]
7. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
8. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
[TBL] [Abstract][Full Text] [Related]
9. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study.
Grazioli L; Morana G; Kirchin MA; Schneider G
Radiology; 2005 Jul; 236(1):166-77. PubMed ID: 15955857
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
Dong Y; Liu Q
J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
[TBL] [Abstract][Full Text] [Related]
11. Detection of small, functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity.
Thoeni RF; Mueller-Lisse UG; Chan R; Do NK; Shyn PB
Radiology; 2000 Feb; 214(2):483-90. PubMed ID: 10671597
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant gynecologic disease: clinical importance of fluid and peritoneal enhancement in the pelvis at MR imaging.
Outwater EK; Siegelman ES; Wilson KM; Mitchell DG
Radiology; 1996 Aug; 200(2):483-8. PubMed ID: 8685345
[TBL] [Abstract][Full Text] [Related]
13. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin-echo MR imaging.
Ito K; Mitchell DG; Outwater EK; Szklaruk J; Sadek AG
Radiology; 1997 Sep; 204(3):729-37. PubMed ID: 9280251
[TBL] [Abstract][Full Text] [Related]
14. Focal liver lesions: characterization with conventional spin-echo versus fast spin-echo T2-weighted MR imaging.
Schima W; Saini S; Echeverri JA; Hahn PF; Harisinghani M; Mueller PR
Radiology; 1997 Feb; 202(2):389-93. PubMed ID: 9015063
[TBL] [Abstract][Full Text] [Related]
15. Myometrial invasion in endometrial cancer: diagnostic accuracy of diffusion-weighted 3.0-T MR imaging--initial experience.
Lin G; Ng KK; Chang CJ; Wang JJ; Ho KC; Yen TC; Wu TI; Wang CC; Chen YR; Huang YT; Ng SH; Jung SM; Chang TC; Lai CH
Radiology; 2009 Mar; 250(3):784-92. PubMed ID: 19244045
[TBL] [Abstract][Full Text] [Related]
16. Performance of spin-echo and gradient-echo T1-weighted sequences for evaluation of dural venous sinus thrombosis and stenosis.
Saindane AM; Mitchell BC; Kang J; Desai NK; Dehkharghani S
AJR Am J Roentgenol; 2013 Jul; 201(1):162-9. PubMed ID: 23789671
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
18. Rectal carcinoma: high-spatial-resolution MR imaging and T2 quantification in rectal cancer specimens.
Stollfuss JC; Becker K; Sendler A; Seidl S; Settles M; Auer F; Beer A; Rummeny EJ; Woertler K
Radiology; 2006 Oct; 241(1):132-41. PubMed ID: 16928975
[TBL] [Abstract][Full Text] [Related]
19. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Jager GJ; Ruijter ET; van de Kaa CA; de la Rosette JJ; Oosterhof GO; Thornbury JR; Ruijs SH; Barentsz JO
Radiology; 1997 Jun; 203(3):645-52. PubMed ID: 9169683
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-enhanced MRI with dynamic evaluation in diagnosing the local recurrence of rectal cancer.
Torricelli P; Pecchi A; Luppi G; Romagnoli R
Abdom Imaging; 2003; 28(1):19-27. PubMed ID: 12483379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
